Jilin Aodong Pharmaceutical Group Co., Ltd.

Equities

000623

CNE000000719

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
15.08 CNY +2.65% Intraday chart for Jilin Aodong Pharmaceutical Group Co., Ltd. +2.17% -0.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% MT
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023. CI
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 21, 2023, has closed with 9,015,780 shares, representing 0.8% for CNY 150 million. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chinese listed firms used endangered animal parts as ingredients -report RE
Three listed Chinese firms used endangered animal parts as ingredients- report RE
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan. CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Elects Liang Biming as Independent Director CI
Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets MT
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023 CI
Jilin Aodong Pharmaceutical Group Co., Ltd Approves the Profit Distribution Proposal for 2022 CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces the Profit Distribution Proposal for 2022 CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022. CI
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022. CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. agreed to acquire Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership), Liu Yujing and other shareholders. CI
Chart Jilin Aodong Pharmaceutical Group Co., Ltd.
More charts
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows: - sale of pharmaceutical products (89.4%); - sale of food products (6.8%); - other (3.8%). All sales are in China.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.08 CNY
Average target price
22.67 CNY
Spread / Average Target
+50.33%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000623 Stock
  4. News Jilin Aodong Pharmaceutical Group Co., Ltd.
  5. Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets